Gasgoo Munich- On Nov. 9, Xiangyu Medical described the current state of its rehabilitation robotics business as the "product registration and clinical penetration phase" at its third-quarter 2026 earnings briefing . The phrasing points to a core challenge: the products are ready, but getting them into hospitals and wards still hinges on securing regulatory approval.
On the product front, the portfolio is relatively complete. The company has established four distinct lines: motor rehabilitation robots, AI physiotherapy robots, nursing and care robots, and traditional Chinese medicine (TCM) acupuncture robots. Recent rollouts include AI infrared moxibustion robots and wearable lower-limb exoskeletons, while several models in the AI physiotherapy series are currently moving through the medical device registration process.
Market penetration isn't starting from scratch. According to the company, related products have already entered hundreds of top-tier (Grade 3A) hospitals nationwide. Yet, bridging the gap between "hospital entry" and "significant revenue" requires clearing several barriers: regulatory certificates determine whether products can be sold legally; hospital access and billing codes dictate whether departments are willing to buy and can charge for services; and the pace of funding for the rehabilitation care expansion project will decide when incremental markets at primary and secondary hospitals truly open up. Xiangyu Medical has identified these three factors as critical variables for future scaling.
On the policy front, momentum is picking up this year. The State Council approved the "Implementation Plan for the Expansion and Upgrade of Medical Rehabilitation and Nursing" in September and officially issued it in October. The plan aims to build a service network anchored by secondary hospitals, with primary care facilities as the foundation and tertiary hospitals providing guidance—thereby expanding the supply of rehabilitation and hospice care. Additionally, the "National Health '15th Five-Year Plan'" calls for intensified training of rehabilitation therapists, setting specific targets for the number of rehabilitation physicians and therapists per 10,000 people.
It is worth noting that while demand growth is a sure thing, procurement is a different story. Overall, equipment upgrades and department construction must navigate budgeting, bidding, and billing coding—meaning actual orders typically lag behind policy directives. For Xiangyu Medical, the key metric to watch in the coming months isn't how many new robots are released, but how many of its three product categories secure regulatory approval and make it into hospital billing directories.
